Mesenchymal stroma: Role in osteosarcoma progression

被引:123
作者
Cortini, Margherita [1 ,2 ]
Avnet, Sofia [1 ]
Baldini, Nicola [1 ,2 ]
机构
[1] Ist Ortoped Rizzoli, Orthopaed Pathophysiol & Regenerat Med Unit, Via Barbiano 1-10, I-40136 Bologna, Italy
[2] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy
关键词
Mesenchymal stroma; Osteosarcoma; Microenvironment; IL-6; Extracellular vesicles; Metabolites; CELLS PROMOTE GROWTH; STEM-CELLS; TUMOR-STROMA; HUMAN BONE; OSTEOGENIC DIFFERENTIATION; MYOFIBROBLASTS CONTRIBUTE; PROGNOSTIC BIOMARKER; SIGNAL TRANSDUCER; GENE-EXPRESSION; IN-VIVO;
D O I
10.1016/j.canlet.2017.07.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The initiation and progression of malignant tumors are supported by their microenvironment: cancer cells per se cannot explain growth and formation of the primary or metastasis, and a combination of proliferating tumor cells, cancer stem cells, immune cells mesenchymal stromal cells and/or cancer-associated fibroblasts all contribute to the tumor bulk. The interaction between these multiple players, under different microenvironmental conditions of biochemical and physical stimuli (i.e. oxygen tension, pH, matrix mechanics), regulates the production and biological activity of several soluble factors, extracellular matrix components, and extracellular vesicles that are needed for growth, maintenance, chemoresistance and metastatization of cancer. In osteosarcoma, a very aggressive cancer of young adults characterized by the extensive need for more effective therapies, this aspect has been only recently explored. In this view, we will discuss the role of stroma, with a particular focus on the mesenchymal stroma, contributing to osteosarcoma progression through inherent features for homing, neo-vascularization, paracrine cross-feeding, microvesicle secretion, and immune modulation, and also by responding to the changes of the microenvironment that are induced by tumor cells. The most recent advances in the molecular cues triggered by cytokines, soluble factors, and metabolites that are partially beginning to unravel the axis between stromal elements of mesenchymal origin and osteosarcoma cells, will be reviewed providing insights likely to be used for novel therapeutic approaches against sarcomas. (c) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:90 / 99
页数:10
相关论文
共 149 条
  • [71] Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
    Karnoub, Antoine E.
    Dash, Ajeeta B.
    Vo, Annie P.
    Sullivan, Andrew
    Brooks, Mary W.
    Bell, George W.
    Richardson, Andrea L.
    Polyak, Kornelia
    Tubo, Ross
    Weinberg, Robert A.
    [J]. NATURE, 2007, 449 (7162) : 557 - U4
  • [72] Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
    Khakoo, Aarif Y.
    Pati, Shibani
    Anderson, Stasia A.
    Reid, William
    Elshal, Mohamed F.
    Rovira, Ilsa I.
    Nguyen, Ahn T.
    Malide, Daniela
    Combs, Christian A.
    Hall, Gentzon
    Zhang, Jianhu
    Raffeld, Mark
    Rogers, Terry B.
    Stetler-Stevenson, William
    Frank, Joseph A.
    Reitz, Marvin
    Finkel, Toren
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (05) : 1235 - 1247
  • [73] Tumor cell-derived exosomes: A message in a bottle
    Kharaziha, Pedram
    Ceder, Sophia
    Li, Qiao
    Panaretakis, Theocharis
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2012, 1826 (01): : 103 - 111
  • [74] Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging
    Kidd, Shannon
    Spaeth, Erika
    Dembinski, Jennifer L.
    Dietrich, Martin
    Watson, Keri
    Klopp, Ann
    Battula, Venkata Lokesh
    Weil, Micheal
    Andreeff, Michael
    Marini, Frank C.
    [J]. STEM CELLS, 2009, 27 (10) : 2614 - 2623
  • [75] Effect of mesenchymal stem cells on hypoxia-induced desensitization of β2-adrenergic receptors in rat osteosarcoma cells
    Kido, Akira
    Yoshitani, Kazuhiro
    Shimizu, Takamasa
    Akahane, Manabu
    Fujii, Hiromasa
    Tsukamoto, Shinji
    Kondo, Yumiko
    Honoki, Kanya
    Imano, Motohiro
    Tanaka, Yasuhito
    [J]. ONCOLOGY LETTERS, 2012, 4 (04) : 745 - 750
  • [76] Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?
    Klopp, Ann H.
    Gupta, Anshul
    Spaeth, Erika
    Andreeff, Michael
    Marini, Frank, III
    [J]. STEM CELLS, 2011, 29 (01) : 11 - 19
  • [77] Therapeutic implications of tumor interstitial acidification
    Kolosenko, Iryna
    Avnet, Sofia
    Baldini, Nicola
    Viklund, Jenny
    De Milito, Angelo
    [J]. SEMINARS IN CANCER BIOLOGY, 2017, 43 : 119 - 133
  • [78] What's new in musculoskeletal oncology
    Lewis, Valerae O.
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2007, 89A (06) : 1399 - 1407
  • [79] CD133 expression in osteosarcoma and derivation of CD133+ cells
    Li, Ji
    Zhong, Xiao-Yan
    Li, Zong-Yu
    Cai, Jin-Fang
    Zou, Lin
    Li, Jian-Min
    Yang, Tao
    Liu, Wei
    [J]. MOLECULAR MEDICINE REPORTS, 2013, 7 (02) : 577 - 584
  • [80] Li N., 2017, CELL MOL LIFE SCI